Original Research
Copyright ©The Author(s) 1997.
World J Gastroenterol. Dec 15, 1997; 3(4): 210-212
Published online Dec 15, 1997. doi: 10.3748/wjg.v3.i4.210
Table 1 Levels of sIL-2R, ALT, and HBV DNA in the sera of patients with chronic HBV infection (mean ± SD)
Purified fractionsTotal protein, mgTotal activity, ×103 USpecific activity, U/mgRecovery, %Purification, -fold
HO-1
Solubilized microsomes8268.6837.51001.0
(64.0-73.2)(781.4-893.6)
DEAE-Sephacel8.718.32097.310.72.5
(16.6-20.0)(1902.9-2291.7)
Hydroxyapatite1.25.14301.11.55.1
(5.0-5.2)(3692.8-4909.3)
HO.2
Solubilized microsomes8268.6837.51001.0
(64.0-73.2)(781.4-893.6)
DEAE-Sephacel4.97.715746.01.9
(7.3-8.0)(1504.5-1643.6)
Hydroxyapatite3.16.72146.33.82.6
(5.3-8.0)(1708.5-2584.0)
Table 2 Purification of HO-2 from treated rat brain microsomal fractions
Purified fractionsTotal protein,mgTotal activity,×103 USpecific activity,U/mgRecovery,%Purification,-fold
HO-2
Solubilized microsomes56.024428.71001.0
(16.9-31.1)(302.7-554.7)
DEAE-Sephacel20.112.2607.735.91.4
(10.3-14.1)(512.0-703.4)
Hydroxyapatite1.610.66478.12.915.1
(10.0-11.2)(6102.4-6853.8)
Table 3 Purification of HO-2 from intact rat liver microsomal fractions
Purified fractionsTotal protein,mgTotal activity,×103 USpecific activity,U/mgRecovery,%Purification,-fold
HO-2
Solubilized microsomes662.7394.7595.61001
(351.8-437.6)(530.9-660.3)
DEAE-Sephacel10.2161574.41.52.6
(13.8-18.2)(1358.7-1789.5)
Hydroxyapatite2.48.23381.60.45.7
(7.3-9.0)(3020.1-3743.2)